Myeloid neoplasm inspired intensive therapy in VEXAS syndrome: A single‐centre experience
British Journal of Haematology · 2025
DOI: 10.1111/bjh.20067 ↗Kurz gefasst
Fallbericht in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Maël Heiblig und 5 weiteren Autor:innen. Beteiligte Einrichtung: Service d'hématologie Clinique, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
There is still no standard of care and unmet medical needs in refractory/advanced VEXAS (vacuoles in myeloid progenitors, E1 ubiquitin activating enzyme, X‐linked, autoinflammatory manifestations and somatic) syndrome with or without associated haematological neoplasm. We report the clinical outcome of four multirefractory/advanced VEXAS patients treated with acute myeloid leukaemia‐like therapeutic approaches. All patients responded to inflammatory/haematological VEXAS‐related features, which were associated with measurable residual disease response (partial or complete). Prospective studies evaluating new and effective therapeutic strategies in order to reduce clonal burden in VEXAS patients are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service d'hématologie Clinique, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France.
- Centre Hospitalier Lyon Sud and Université Claude Bernard Lyon-1, Pierre-Bénite, France.
- Team Lymphoma Immuno-Biology, Centre International de Recherche en Infectiologie (CIRI), UMR INSERM U1111, CNRS 5308, Université Claude Bernard Lyon I, ENS de Lyon, Lyon, France.
- Service d'hématologie biologique, Hospices Civils de Lyon, Lyon, France.
- Service d'anatomopathologie, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France.
- Service de Médecine Interne, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France.
ORCID-Profile: Maël Heiblig, Pierre Sujobert
Zitieren
APA
Heiblig, M., Plesa, A., Tantot, J., Jamilloux, Y., Labussière-Wallet, H., & Sujobert, P. (2025). Myeloid neoplasm inspired intensive therapy in VEXAS syndrome: A single‐centre experience. British Journal of Haematology. https://doi.org/10.1111/bjh.20067
Vancouver
Heiblig M, Plesa A, Tantot J, Jamilloux Y, Labussière-Wallet H, Sujobert P. Myeloid neoplasm inspired intensive therapy in VEXAS syndrome: A single‐centre experience. British Journal of Haematology. 2025. doi:10.1111/bjh.20067
BibTeX
@article{Heiblig2025,
author = {Heiblig, Maël and Plesa, Adriana and Tantot, Juliet and Jamilloux, Yvan and Labussière-Wallet, Hélène and Sujobert, Pierre},
title = {Myeloid neoplasm inspired intensive therapy in VEXAS syndrome: A single‐centre experience},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.20067}
}
EUVIMED